N/A N=15 Randomized Single-blind Treatment

staRt: Enhancing Speech Treatment With Smartphone-delivered Biofeedback

Speech Sound Disorder

Bottom Line

View on ClinicalTrials.gov: NCT04474691 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

May 2023

Primary outcome: Primary: F3-F2 Distance, an Acoustic Measure That Correlates With Perceptual Accuracy of /r/, Measured From /r/ Sounds Produced in Treatment Sessions. — 1793.3; 1772.2 Hz — p=.67

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Traditional articulation treatment (Behavioral); Visual-acoustic biofeedback (Behavioral)
Age: Pediatric · 8+ yrs
Sex: All
Sponsor: New York University
Primary completion: Aug 2019

Outcome Measures

Outcome	Result	p-value
PRIMARY F3-F2 Distance, an Acoustic Measure That Correlates With Perceptual Accuracy of /r/, Measured From /r/ Sounds Produced in Treatment Sessions.	1793.3; 1772.2	.67

Summary

Previous research suggests that biofeedback can outperform traditional interventions for RSE, but no controlled studies have tested this hypothesis in the context of app-delivered biofeedback. The objective of this aim is to use the staRt app to test our working hypothesis that speakers will make larger gains in /r/ accuracy when app-based treatment incorporates biofeedback, compared to a non-biofeedback condition. With a network of cooperating SLPs, this project will recruit 15 children with /r/ misarticulation to receive 8 weeks of intervention using staRt. Individual sessions will be randomly assigned to include or exclude the visual biofeedback display. Randomization tests will be used to evaluate, for each individual, whether larger increments of change are associated with biofeedback and non-biofeedback sessions.

Eligibility Criteria

Inclusion Criteria

Normal performance on a pure-tone hearing screening at 20 dB HL, a screening examination of oral-motor structure and function, and a test of receptive language.

Exclusion Criteria

History of major behavioral, neurological, or hearing impairment, per parent and/or SLP report.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04474691). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.